Literature DB >> 20716766

von Willebrand factor promotes leukocyte extravasation.

Björn Petri1, Andre Broermann, Hang Li, Alexander G Khandoga, Alexander Zarbock, Fritz Krombach, Tobias Goerge, Stefan W Schneider, Claire Jones, Bernhard Nieswandt, Martin K Wild, Dietmar Vestweber.   

Abstract

von Willebrand factor (VWF) is an important player in hemostasis but has also been suggested to promote inflammatory processes. Gene ablation of VWF causes a simultaneous defect in P-selectin expression making it difficult to identify VWF-specific functions. Therefore, we analyzed whether blocking antibodies against VWF would be able to interfere with neutrophil extravasation. We found that these antibodies inhibited neutrophil recruitment into thioglycollate-inflamed peritoneum and KC-stimulated cremaster by approximately 50%. Whereas platelet-VWF was not involved, the contribution of VWF to granulocyte recruitment was strictly dependent on the presence of platelets and the accessibility of their VWF-receptor glycoprotein Ib. Surprisingly, platelet P-selectin was largely dispensable for leukocyte extravasation, in agreement with our observation that anti-VWF antibodies did not affect leukocyte rolling and adhesion. Searching for possible effects downstream of leukocyte capture, we found that anti-VWF antibodies significantly inhibited thioglycollate-induced vascular permeability. The increase of permeability was independent of circulating granulocytes, showing that it was not a side effect of neutrophil diapedesis. Collectively, our results demonstrate that VWF-associated platelets strongly support neutrophil extravasation at a step downstream of leukocyte docking to the vessel wall. This step could be related to leukocyte diapedesis facilitated by destabilization of the endothelial barrier.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20716766     DOI: 10.1182/blood-2010-03-276311

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  80 in total

1.  Niacin and biosynthesis of PGD₂by platelet COX-1 in mice and humans.

Authors:  Wen-Liang Song; Jane Stubbe; Emanuela Ricciotti; Naji Alamuddin; Salam Ibrahim; Irene Crichton; Maxwell Prempeh; John A Lawson; Robert L Wilensky; Lars Melholt Rasmussen; Ellen Puré; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

2.  Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture.

Authors:  Shogo Kasuda; Hideto Matsui; Shiro Ono; Yasunori Matsunari; Kenji Nishio; Midori Shima; Katsuhiko Hatake; Mitsuhiko Sugimoto
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941

3.  Von Willebrand factor parameters as potential biomarkers for disease activity and coronary artery lesion in patients with Kawasaki disease.

Authors:  André Jakob; Eva Schachinger; Simon Klau; Anja Lehner; Sarah Ulrich; Brigitte Stiller; Barbara Zieger
Journal:  Eur J Pediatr       Date:  2019-11-23       Impact factor: 3.183

4.  Noninvasive Evaluation of No-Reflow Phenomenon.

Authors:  Albert J Sinusas
Journal:  Circ Cardiovasc Imaging       Date:  2018-11       Impact factor: 7.792

5.  Endothelial alterations in a canine model of immune thrombocytopenia.

Authors:  Dana N LeVine; Rachel E Cianciolo; Keith E Linder; Petra Bizikova; Adam J Birkenheuer; Marjory B Brooks; Abdelghaffar K Salous; Shila K Nordone; Dwight A Bellinger; Henry Marr; Sam L Jones; Thomas H Fischer; Yu Deng; Marshall Mazepa; Nigel S Key
Journal:  Platelets       Date:  2017-11-28       Impact factor: 3.862

6.  Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability.

Authors:  Dörte Schulte; Verena Küppers; Nina Dartsch; Andre Broermann; Hang Li; Alexander Zarbock; Olena Kamenyeva; Friedemann Kiefer; Alexander Khandoga; Steffen Massberg; Dietmar Vestweber
Journal:  EMBO J       Date:  2011-08-19       Impact factor: 11.598

7.  Von Willebrand factor protects against acute CCl4-induced hepatotoxicity through phospho-p38 MAPK signaling pathway inhibition.

Authors:  Hai-Jian Sun; Jian Chen; Hao Zhang; Bing Ni; Jennifer C van Velkinburgh; Yao Liu; Yu-Zhang Wu; Xia Yang
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

Review 8.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

9.  The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation.

Authors:  Anna Theiler; Viktoria Konya; Lisa Pasterk; Jovana Maric; Thomas Bärnthaler; Ilse Lanz; Wolfgang Platzer; Rufina Schuligoi; Akos Heinemann
Journal:  Vascul Pharmacol       Date:  2016-09-21       Impact factor: 5.773

10.  Discs large 1 (Dlg1) scaffolding protein participates with clathrin and adaptator protein complex 1 (AP-1) in forming Weibel-Palade bodies of endothelial cells.

Authors:  Monique Philippe; Thibaut Léger; Raphaëlle Desvaux; Laurence Walch
Journal:  J Biol Chem       Date:  2013-03-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.